skip to Main Content

Merck KGaA invests in antibody-drug conjugates

Read the full press release here Merck KGaA plans to spend $65 million to expand a plant near Madison, Wisconsin, that makes cancer-fighting antibody-drug conjugates for drug industry customers. The German firm says it will add a building that will…

Read More
Back To Top